Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
May 12, 2026 by statnews.com
No FDA permission, no problem: New flavored vape policy worries experts
The U.S. Food and Drug Administration is facing growing scrutiny after introducing new guidance that eases enforcement against some unauthorised vaping and nicotine products currently under review. Critics argue that the policy could allow more flavoured products to remain on the market without formal authorisation, raising concerns about industry influence and political pressure. The shift comes shortly after the FDA authorised fruit-flavoured vape products for the first time in the United States, signalling a significant change in the agency’s regulatory approach. Supporters of the move argue that regulated flavoured alternatives may help adult smokers switch away from cigarettes, particularly when combined with strict age-verification technology. At the same time, public health experts warn that loosening oversight could increase youth appeal and weaken confidence in the FDA’s scientific independence.
The debate reflects broader tensions between harm reduction, political influence and youth protection in shaping future nicotine policy in the United States.
May 12, 2026 by marijuanamoment.net
Congressional Committee Directs DEA To Crack Down On Unregulated Cannabis Products That ‘Threaten Consumer Safety’
The House Appropriations Committee is expected to approve a report directing the DEA and FDA to address unregulated cannabinoid products threatening consumer safety. The directive also targets money laundering schemes linked to Chinese-connected illegal marijuana businesses and proposes wastewater surveillance in federal prisons. The report is part of a spending bill covering various agencies and responds to concerns regarding the proliferation of intoxicating cannabinoids. Additionally, the legislation blocks the rescheduling of cannabis and protects state medical cannabis programs. The House is focusing on health risks from cannabis products and research on psychedelics, while a separate bill aids industrial hemp producers. Future legislation may allow military veterans access to medical marijuana recommendations.
May 12, 2026 by aol.com
Texas court says nicotine pouches are tobacco products
A Texas court has ruled that nicotine pouches cannot automatically be treated the same as traditional smokeless tobacco products under existing state law. The decision centres on how these products are legally defined, particularly as nicotine pouches contain no tobacco leaf despite delivering nicotine. The ruling could have broader implications for taxation, regulation and how alternative nicotine products are classified across the United States. Critics of stricter regulation argue that treating tobacco-free nicotine products identically to cigarettes or chewing tobacco ignores important differences in risk profiles. The case reflects the growing legal and policy debate over how newer nicotine alternatives should fit within frameworks originally designed for combustible or traditional tobacco products.
May 11, 2026 by dcjournal.com
The War On Tobacco Is Producing Predictable Consequences
Heavy taxation and strict regulation of products often lead to unintended consequences, including the growth of black markets and illicit trade. Historical examples, such as alcohol prohibition in the United States, show this pattern clearly. A recent KPMG report highlights similar issues in Latin America and Canada, where high tobacco taxes and restrictive policies have contributed to increased smuggling and criminal activity. The argument suggests that governments should reconsider heavy-handed approaches and instead adopt more balanced, consumer-focused regulation.
May 08, 2026 by qz.com
FDA authorizes fruit-flavored e-cigarettes for the first time
The FDA on Tuesday authorized the sale of fruit-flavored electronic cigarettes for the first time, clearing four products from Los Angeles-based vaping company Glas Inc. for adult use in the U.S. The authorized products — marketed under the names Gold, Sapphire, Classic Menthol, and Fresh Menthol — are e-liquid pods containing 50mg/ml of tobacco-derived nicotine, according to the FDA. Gold and Sapphire are mango and blueberry flavors, respectively, according to NBC News. Until Tuesday's action, every federally authorized vaping product had been either tobacco- or menthol-flavored.
May 07, 2026 by filtermag.org
FDA Finally Authorizes Fruit-Flavored Vapes. Here’s What It Took.
The United States has authorised fruit-flavoured vaping products for the first time, marking a major shift in federal nicotine regulation. The U.S. Food and Drug Administration approved mango and blueberry vape pods after determining that new age-verification technology could help limit youth access. For years, concerns over underage vaping had been the main reason flavoured products were denied authorisation in the US market. Supporters argue that flavoured alternatives may help adult smokers move away from cigarettes, particularly as smoking cessation tools evolve. At the same time, public health organisations warn that the decision could increase youth appeal and reverse progress made in reducing teenage vaping rates. The move reflects a broader shift in the ongoing debate over how to balance harm reduction, adult choice and youth protection in nicotine policy.
April 30, 2026 by realclearscience.com
When Public Health Ignores the Evidence on Heated Tobacco
Debate over heated tobacco products is intensifying as regulators and public health advocates interpret the evidence in different ways. Authorisation decisions by the U.S. Food and Drug Administration have recognised that some products can reduce exposure to harmful chemicals compared to cigarettes. This distinction is based on extensive scientific review, highlighting the role of combustion—not nicotine itself—as the primary source of harm. However, critics argue that parts of the public health community continue to downplay or reject these findings, creating confusion around relative risk. Such messaging may discourage smokers from switching to potentially less harmful alternatives, undermining harm reduction efforts. The debate ultimately reflects a wider divide between evidence-based regulatory assessments and broader public health narratives on tobacco and nicotine.
April 30, 2026 by regulatorwatch.com
Blind Spots | Cliff Douglas on Makary Flavor Denials | RegWatch
Concerns are growing over how decisions on flavoured vaping products are being made within the United States regulatory system. Discussion around U.S. Food and Drug Administration highlights claims that scientific evidence supporting certain products may not be fully reflected in final decisions. Experts point to potential “blind spots” in how data is interpreted, particularly when it comes to evaluating the role of flavours in helping adults switch from smoking. The debate raises questions about consistency between the agency’s scientific mandate and its regulatory outcomes. Critics argue that overly cautious or restrictive decisions could limit access to alternatives for smokers.At the same time, the controversy reflects broader tensions over how evidence, risk and public health priorities are balanced in nicotine policy.
April 30, 2026 by regulatorwatch.com
Blind Spots | Cliff Douglas on Makary Flavor Denials | RegWatch
Concerns are growing over how decisions on flavoured vaping products are being made within the United States regulatory system. Discussion around U.S. Food and Drug Administration highlights claims that scientific evidence supporting certain products may not be fully reflected in final decisions. Experts point to potential “blind spots” in how data is interpreted, particularly when it comes to evaluating the role of flavours in helping adults switch from smoking. The debate raises questions about consistency between the agency’s scientific mandate and its regulatory outcomes. Critics argue that overly cautious or restrictive decisions could limit access to alternatives for smokers.At the same time, the controversy reflects broader tensions over how evidence, risk and public health priorities are balanced in nicotine policy.
April 27, 2026 by regulatorwatch.com
Renegade Regulator | FDA Chief Blocks White House Push for Flavors | RegWatch
Tensions are rising within the US administration over the future of flavoured nicotine products. Reports suggest that the head of the U.S. Food and Drug Administration is resisting pressure from the White House to relax restrictions on flavours. The dispute highlights internal divisions over how to balance youth protection with harm reduction strategies. Critics argue that limiting flavoured alternatives could reduce options for adult smokers trying to switch. The situation reflects a broader struggle over how nicotine policy should be shaped and on what evidence.